In addition, STAU1 elevation in cultured ALS cells (Fig. 2 and Supplementary Fig. 2e), supports that STAU1 could be a therapeutic target for multiple neurodegenerative diseases. The gene discussed is STAU1; the disease is amyotrophic lateral sclerosis.